Balovaptan

Balovaptan is a selective, orally administered, brain-penetrant vasopressin 1A (V1A) receptor antagonist that has been investigated for treating social communication difficulties, particularly in autism spectrum disorder. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include RG-7314 and RO5285119. Its PubChem CID is 46200932.

CAS No 1228088-30-9
Molecular Formula C22H24ClN5O
Molecular Weight 409.9 g/mol
Synonyms 8-chloro-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

Frequently Asked Questions